Which has preferable earnings & valuation, BLLN or FTRE?

Billiontoone has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $305.11M 18.58 $7.45M $0.55 224.09 Fortrea $2.72B 0.62 -$986.20M -$4.91 N/A

Does the media favor BLLN or FTRE?

In the previous week, Billiontoone had 1 more articles in the media than Fortrea. MarketBeat recorded 12 mentions for Billiontoone and 11 mentions for Fortrea. Fortrea's average media sentiment score of 0.67 beat Billiontoone's score of -0.17 indicating that Fortrea is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Fortrea 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, RDNT or FTRE?

RadNet has higher earnings, but lower revenue than Fortrea. RadNet is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.04B 2.44 -$18.65M -$0.18 N/A Fortrea $2.72B 0.62 -$986.20M -$4.91 N/A

Is RDNT or FTRE more profitable?

RadNet has a net margin of -0.66% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat RadNet's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% Fortrea -16.50% 9.51% 1.96%

Does the media prefer RDNT or FTRE?

In the previous week, Fortrea had 8 more articles in the media than RadNet. MarketBeat recorded 11 mentions for Fortrea and 3 mentions for RadNet. RadNet's average media sentiment score of 1.38 beat Fortrea's score of 0.67 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is FTRE or CELC more profitable?

Celcuity has a net margin of 0.00% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Fortrea -16.50% 9.51% 1.96% Celcuity N/A -244.61% -50.22%

Does the media favor FTRE or CELC?

In the previous week, Fortrea had 8 more articles in the media than Celcuity. MarketBeat recorded 11 mentions for Fortrea and 3 mentions for Celcuity. Celcuity's average media sentiment score of 1.76 beat Fortrea's score of 0.67 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to FTRE or CAI?

In the previous week, Fortrea had 4 more articles in the media than Caris Life Sciences. MarketBeat recorded 11 mentions for Fortrea and 7 mentions for Caris Life Sciences. Caris Life Sciences' average media sentiment score of 1.04 beat Fortrea's score of 0.67 indicating that Caris Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Caris Life Sciences 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is FTRE or SHC more profitable?

Sotera Health has a net margin of 9.91% compared to Fortrea's net margin of -16.50%. Sotera Health's return on equity of 39.73% beat Fortrea's return on equity. Company Net Margins Return on Equity Return on Assets Fortrea -16.50% 9.51% 1.96% Sotera Health 9.91% 39.73% 7.05%

Does the media prefer FTRE or SHC?

In the previous week, Fortrea had 8 more articles in the media than Sotera Health. MarketBeat recorded 11 mentions for Fortrea and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.83 beat Fortrea's score of 0.67 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fortrea 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Fortrea (FTRE) Competitors

$17.86 +0.10 (+0.56%)

Closing price 07/13/2026 04:00 PM Eastern

Extended Trading

$17.88 +0.02 (+0.11%)

As of 07/13/2026 06:18 PM Eastern

Compare

FTRE vs. BLLN, RDNT, CELC, CAI, and SHC

Should you buy Fortrea stock or one of its competitors? MarketBeat compares Fortrea with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fortrea include Billiontoone (BLLN), RadNet (RDNT), Celcuity (CELC), Caris Life Sciences (CAI), and Sotera Health (SHC). These companies are all part of the "healthcare" industry.

How does Fortrea compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Fortrea (NASDAQ:FTRE) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

Billiontoone has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	18.58	$7.45M	$0.55	224.09
Fortrea	$2.72B	0.62	-$986.20M	-$4.91	N/A

Billiontoone has a net margin of 0.00% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Fortrea	-16.50%	9.51%	1.96%

Billiontoone currently has a consensus price target of $126.00, indicating a potential upside of 2.23%. Fortrea has a consensus price target of $17.75, indicating a potential downside of 0.62%. Given Billiontoone's higher probable upside, equities analysts clearly believe Billiontoone is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Fortrea	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

In the previous week, Billiontoone had 1 more articles in the media than Fortrea. MarketBeat recorded 12 mentions for Billiontoone and 11 mentions for Fortrea. Fortrea's average media sentiment score of 0.67 beat Billiontoone's score of -0.17 indicating that Fortrea is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fortrea	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Billiontoone beats Fortrea on 8 of the 14 factors compared between the two stocks.

How does Fortrea compare to RadNet?

RadNet (NASDAQ:RDNT) and Fortrea (NASDAQ:FTRE) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, dividends, institutional ownership and analyst recommendations.

RadNet currently has a consensus price target of $87.43, suggesting a potential upside of 38.10%. Fortrea has a consensus price target of $17.75, suggesting a potential downside of 0.62%. Given RadNet's stronger consensus rating and higher probable upside, research analysts plainly believe RadNet is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Fortrea	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55

RadNet has a net margin of -0.66% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Fortrea	-16.50%	9.51%	1.96%

RadNet has higher earnings, but lower revenue than Fortrea. RadNet is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.44	-$18.65M	-$0.18	N/A
Fortrea	$2.72B	0.62	-$986.20M	-$4.91	N/A

RadNet has a beta of 1.37, suggesting that its stock price is 37% more volatile than the broader market. Comparatively, Fortrea has a beta of 2.03, suggesting that its stock price is 103% more volatile than the broader market.

In the previous week, Fortrea had 8 more articles in the media than RadNet. MarketBeat recorded 11 mentions for Fortrea and 3 mentions for RadNet. RadNet's average media sentiment score of 1.38 beat Fortrea's score of 0.67 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fortrea	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

77.9% of RadNet shares are owned by institutional investors. 5.6% of RadNet shares are owned by insiders. Comparatively, 0.7% of Fortrea shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

RadNet beats Fortrea on 11 of the 17 factors compared between the two stocks.

How does Fortrea compare to Celcuity?

Fortrea (NASDAQ:FTRE) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

Fortrea has a beta of 2.03, suggesting that its stock price is 103% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.16, suggesting that its stock price is 84% less volatile than the broader market.

63.3% of Celcuity shares are owned by institutional investors. 0.7% of Fortrea shares are owned by company insiders. Comparatively, 13.3% of Celcuity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Celcuity has a net margin of 0.00% compared to Fortrea's net margin of -16.50%. Fortrea's return on equity of 9.51% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Celcuity	N/A	-244.61%	-50.22%

In the previous week, Fortrea had 8 more articles in the media than Celcuity. MarketBeat recorded 11 mentions for Fortrea and 3 mentions for Celcuity. Celcuity's average media sentiment score of 1.76 beat Fortrea's score of 0.67 indicating that Celcuity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Fortrea presently has a consensus target price of $17.75, suggesting a potential downside of 0.62%. Celcuity has a consensus target price of $152.09, suggesting a potential upside of 46.54%. Given Celcuity's stronger consensus rating and higher probable upside, analysts plainly believe Celcuity is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

Celcuity has lower revenue, but higher earnings than Fortrea. Celcuity is trading at a lower price-to-earnings ratio than Fortrea, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.62	-$986.20M	-$4.91	N/A
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

Summary

Celcuity beats Fortrea on 9 of the 16 factors compared between the two stocks.

How does Fortrea compare to Caris Life Sciences?

Fortrea (NASDAQ:FTRE) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Fortrea currently has a consensus price target of $17.75, suggesting a potential downside of 0.62%. Caris Life Sciences has a consensus price target of $26.11, suggesting a potential upside of 53.05%. Given Caris Life Sciences' higher probable upside, analysts plainly believe Caris Life Sciences is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

In the previous week, Fortrea had 4 more articles in the media than Caris Life Sciences. MarketBeat recorded 11 mentions for Fortrea and 7 mentions for Caris Life Sciences. Caris Life Sciences' average media sentiment score of 1.04 beat Fortrea's score of 0.67 indicating that Caris Life Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Caris Life Sciences	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Caris Life Sciences has a net margin of 3.75% compared to Fortrea's net margin of -16.50%. Caris Life Sciences' return on equity of 98.28% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Caris Life Sciences	3.75%	98.28%	48.87%

Caris Life Sciences has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.62	-$986.20M	-$4.91	N/A
Caris Life Sciences	$812.03M	5.94	-$68.09M	-$7.61	N/A

Summary

Caris Life Sciences beats Fortrea on 9 of the 14 factors compared between the two stocks.

How does Fortrea compare to Sotera Health?

Fortrea (NASDAQ:FTRE) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

Fortrea has a beta of 2.03, indicating that its stock price is 103% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.76, indicating that its stock price is 76% more volatile than the broader market.

91.0% of Sotera Health shares are held by institutional investors. 0.7% of Fortrea shares are held by company insiders. Comparatively, 15.4% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sotera Health has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fortrea	$2.72B	0.62	-$986.20M	-$4.91	N/A
Sotera Health	$1.16B	4.45	$77.94M	$0.41	44.32

In the previous week, Fortrea had 8 more articles in the media than Sotera Health. MarketBeat recorded 11 mentions for Fortrea and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.83 beat Fortrea's score of 0.67 indicating that Sotera Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fortrea	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Fortrea presently has a consensus target price of $17.75, indicating a potential downside of 0.62%. Sotera Health has a consensus target price of $20.25, indicating a potential upside of 11.45%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Fortrea.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fortrea	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.55
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Sotera Health has a net margin of 9.91% compared to Fortrea's net margin of -16.50%. Sotera Health's return on equity of 39.73% beat Fortrea's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fortrea	-16.50%	9.51%	1.96%
Sotera Health	9.91%	39.73%	7.05%

Summary

Sotera Health beats Fortrea on 13 of the 17 factors compared between the two stocks.

Get Fortrea News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FTRE vs. The Competition

Export

Metric	Fortrea	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.68B	$3.71B	$7.05B	$12.61B
Dividend Yield	N/A	2.20%	2.68%	8.00%
P/E Ratio	-3.64	20.85	27.11	24.26
Price / Sales	0.62	314.01	587.92	117.88
Price / Cash	1.79	61.98	29.22	49.36
Price / Book	2.93	8.49	10.75	6.29
Net Income	-$986.20M	$23.83M	$3.58B	$330.66M
7 Day Performance	2.17%	-3.56%	-2.06%	-1.32%
1 Month Performance	8.37%	6.31%	3.32%	-0.64%
1 Year Performance	256.49%	48.30%	26.36%	19.08%

Fortrea Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FTRE Fortrea	2.5714 of 5 stars	$17.86 +0.6%	$17.75 -0.6%	+249.5%	$1.68B	$2.72B	N/A	14,300	News Coverage Analyst Upgrade
BLLN Billiontoone	1.7403 of 5 stars	$123.40 +2.5%	$126.00 +2.1%	N/A	$5.54B	$305.11M	N/A	620	News Coverage Insider Trade
RDNT RadNet	3.6025 of 5 stars	$68.92 +0.2%	$87.43 +26.9%	+14.1%	$5.41B	$2.04B	N/A	11,264
CELC Celcuity	3.6983 of 5 stars	$108.58 +0.6%	$152.09 +40.1%	+661.5%	$5.26B	N/A	N/A	40	Positive News
CAI Caris Life Sciences	4.4452 of 5 stars	$17.81 -2.7%	$26.11 +46.6%	N/A	$5.17B	$812.03M	N/A	1,846	Positive News Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FTRE) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fortrea (FTRE) Competitors

FTRE vs. BLLN, RDNT, CELC, CAI, and SHC

How does Fortrea compare to Billiontoone?

Summary

How does Fortrea compare to RadNet?

Summary

How does Fortrea compare to Celcuity?

Summary

How does Fortrea compare to Caris Life Sciences?

Summary

How does Fortrea compare to Sotera Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fortrea (FTRE) Competitors

FTRE vs. BLLN, RDNT, CELC, CAI, and SHC

How does Fortrea compare to Billiontoone?

Which has preferable earnings & valuation, BLLN or FTRE?

Is BLLN or FTRE more profitable?

Do analysts recommend BLLN or FTRE?

Does the media favor BLLN or FTRE?

Summary

How does Fortrea compare to RadNet?

Do analysts prefer RDNT or FTRE?

Is RDNT or FTRE more profitable?

Which has better earnings and valuation, RDNT or FTRE?

Which has more risk & volatility, RDNT or FTRE?

Does the media prefer RDNT or FTRE?

Do institutionals & insiders hold more shares of RDNT or FTRE?

Summary

How does Fortrea compare to Celcuity?

Which has more risk & volatility, FTRE or CELC?

Do insiders & institutionals hold more shares of FTRE or CELC?

Is FTRE or CELC more profitable?

Does the media favor FTRE or CELC?

Do analysts rate FTRE or CELC?

Which has stronger valuation & earnings, FTRE or CELC?

Summary

How does Fortrea compare to Caris Life Sciences?

Do analysts rate FTRE or CAI?

Does the media refer more to FTRE or CAI?

Is FTRE or CAI more profitable?

Which has preferable valuation & earnings, FTRE or CAI?

Summary

How does Fortrea compare to Sotera Health?

Which has more volatility and risk, FTRE or SHC?

Do institutionals and insiders believe in FTRE or SHC?

Which has better earnings and valuation, FTRE or SHC?

Does the media prefer FTRE or SHC?

Do analysts prefer FTRE or SHC?

Is FTRE or SHC more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE vs. The Competition

Fortrea Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools